Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHaydale Plc Regulatory News (HAYD)

Share Price Information for Haydale Plc (HAYD)

Share Price is delayed by 15 minutes
Get Live Data
0.3275    0.00 (0.00%)
Bid:
0.325
Ask:
0.33
Spread: 0.005 (1.538%)
Market Cap: £25.46m
HAYD Live PriceLast checked at - London Stock Exchange

Intraday Haydale Plc Share Chart

Distribution Agreement

13 Oct 2016 07:00

RNS Number : 3701M
Haydale Graphene Industries PLC
13 October 2016
 

 

Haydale Graphene Industries plc

 

("Haydale" or the "Group")

 

Distribution Agreement for Graphene Enhanced PLA Filaments for 3D Printing

 

Haydale Graphene Industries plc (AIM: HAYD), the Group focused on the application and sale of enabling technology for graphene enhanced materials and products is pleased to announce that Haydale Composite Solutions Ltd ("HCS") a wholly owned subsidiary of Haydale has appointed 3DFilaPrint as its distributor of their graphene enhanced 3D Printing PLA filaments in the United Kingdom and Eire ("Agreement").

 

Following the launch of Haydale's graphene enhanced PLA filaments (see Company announcement dated 11 August 2016), HCS received over 140 enquires from universities, 3D printers, 3D equipment manufacturers and 3D filament distributors from all over the world at the recent TCT show in Birmingham. 3DFilaPrint and HCS also gave out over 100 test sample spools to potential customers.

3DFilaPrint are now selling Haydale graphene enhanced PLA on their website (http://shop.3dfilaprint.com) which is going to be the first of a family of graphene enhanced thermoplastic filaments with improved mechanical, electrical, thermal or physical property improvements. This first graphene enhanced PLA has already been sampled by several 3D printers who have confirmed it out performs engineering polymers such as ABS and PETG in terms of temperature performance, is very easy to print, provides an excellent surface finish, has improved first layer and inter-layer adhesion with excellent dimensional stability and reduced warpage.

Further details of the Agreement

The Agreement is initially for a period of one year. The Agreement includes certain order quantities of products expected to be purchased each quarter by 3DFilaPrint from HCS (such amounts increasing quarterly over the initial duration of the contract). The expected order quantities are not however guaranteed

Gerry Boyce, Managing Director of HCS commented:

"We are very pleased with the successful launch of this new product at the TCT show and positive feedback from the 3D printing trials conducted on our graphene enhanced PLA. Since commencing our collaboration with 3DFilaPrint, it was evident they were ideally suited to be our distributor in the UK and Eire. We continue to receive interest from companies all over the world wishing to act as distributors for Haydale, which we will assess. In addition, we are comforted by the number of large industrial companies approaching us to develop bespoke materials for their individual needs."

Commenting on the UK and Eire distributorship, Tim Kay from 3DFilaPrint commented:

"During printing trials, we were very impressed with the graphene enhanced PLA filament and can see a major opportunity to offer this new material in the market place. PLA based filaments are relatively easy to 3D print with and the addition of graphene has made this into a material with engineering or industrial properties and we look forward to working with our clients and HCS on selling this material into the market place as well as advising on the next generation of products."

 

- Ends -

 

For further information, please contact:

 

Haydale Graphene Industries plc

+44 (0) 1269 842 946

John Knowles, Chairman

Ray Gibbs, Chief Executive Officer

 

 

Cairn Financial Advisers LLP (Nomad)

+44 (0) 20 7148 7900

Tony Rawlinson

Emma Earl

 

 

Cantor Fitzgerald Europe (Broker)

+44 (0) 20 7894 7000

David Foreman (Corporate Finance)

Will Goode (Corporate Finance)

David Banks (Sales)

Mark Westcott (Sales)

 

 

Hermes Financial PR

 

Trevor Phillips

Chris Steele

+44 (0) 7889 153 628

+44 (0) 7979 604 687

 

 

About Haydale

Haydale has developed a patented scalable plasma process to functionalise graphene and other nanomaterials. This enabling technology can provide Haydale with a rapid and highly cost-efficient method of supplying tailored solutions to enhance applications for both raw material suppliers and product manufacturers.

Functionalisation is carried out through a patented low-pressure plasma process that treats both mined, organic fine powder and other synthetically produced nanomaterial powders, producing high-quality few layered graphene and graphene nanoplatelets. The process can functionalise with a range of chemical groups, with the level of functionalisation tailored to the customer's needs. Good dispersion improves the properties and performance of the host material and ensures the final product performs as specified.

The Haydale plasma process does not use wet chemistry, nor does it damage the material being processed; rather, it can clean up any impurities inherent in the raw material. The technology is a low energy user and most importantly environmentally friendly. The Haydale process is a patented enabling technology, allowing the Group to work with a raw material producer who seeks to add value to the base product and tailor the outputs to meet the target applications of the end user.

Haydale, based in South Wales and housed in a purpose-built facility for processing and handling nanomaterials, is facilitating the application of graphene and other nanomaterials in fields such as inks, sensors, energy storage, composites, paints and coatings.

www.haydale.com Twitter: @haydalegraphene

 

About Haydale Composite Solutions (HCS)

Haydale Composite Solutions Ltd ("HCS") is based in Loughborough UK and is a wholly owned subsidiary of Haydale Graphene Industries plc ("HGI"). HCS (previously known as EPL Composite Solutions Ltd was acquired by HGI in November 2014) has developed a reputation for delivering innovative solutions in the commercial applications of advanced polymer composite materials working with global companies over more than 20 years. HCS are tasked with developing new markets and applications for graphene enhanced nanocomposite materials across a broad range of industries.

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
NRAAKBDPKBDDCKD
Date   Source Headline
21st May 20267:05 amRNSProposed Commercial Relationship
8th Apr 20265:18 pmRNSDirector/PDMR Shareholding
7th Apr 20267:00 amRNSNew Contract Signed
26th Mar 20263:39 pmRNSResult of AGM
6th Mar 20261:31 pmRNSInvestor Presentation via Investor Meet Company
2nd Mar 20267:00 amRNSStrategic Digital Infrastructure Partnership
17th Feb 20267:00 amRNSFinal Results and Post-Period Trading Update
11th Feb 20267:00 amRNSNotice of Annual Results
30th Jan 20269:45 amRNSTotal Voting Rights
22nd Jan 20264:54 pmRNSHolding(s) in Company
22nd Jan 20267:00 amRNSHolding(s) in Company
21st Jan 202612:31 pmRNSHolding(s) in Company
15th Jan 20265:01 pmRNSHolding(s) in Company
15th Jan 20262:44 pmRNSChange of Name
12th Jan 20267:00 amRNSCompletion of Acquisition
9th Jan 20266:19 pmRNSDirector/PDMR Dealings
8th Jan 20261:59 pmRNSHolding(s) in Company
8th Jan 20261:55 pmRNSHolding(s) in Company
6th Jan 20262:45 pmRNSResult of General Meeting and Total Voting Rights
22nd Dec 20252:08 pmRNSHolding(s) in Company
22nd Dec 20252:08 pmRNSHolding(s) in Company
16th Dec 202512:45 pmRNSResult of Retail Offer
15th Dec 20259:14 amRNSResult of Accelerated Bookbuild
12th Dec 20257:05 amRNSRetail Offer
12th Dec 20257:00 amRNSProposed Fundraise and Acquisition
2nd Dec 20257:00 amRNSCommercial Update
30th Oct 202510:45 amRNSExpansion of Commercial Platform
23rd Oct 20257:00 amRNSContract Wins
11th Sep 20257:00 amRNSStrategic Collaboration and Trading Update
8th Aug 20257:00 amRNSGrant of Share Options and PDMR Dealings
11th Jul 20258:21 amRNSHolding(s) in Company
30th Jun 20253:14 pmRNSHolding(s) in Company
26th Jun 20252:00 pmRNSSubscriptions, Director Dealings & Issue of Equity
12th Jun 20252:12 pmRNSTrading Update
23rd Apr 20255:22 pmRNSDirectorate Change
17th Apr 202510:46 amRNSCorrection: Haydale US Sales Process Update
17th Apr 20257:00 amRNSHaydale US Sales Process Update
2nd Apr 20257:00 amRNSHaydale Achieves CE Certification
13th Mar 20252:15 pmRNSSubscription, Director Dealings and TVR
13th Mar 20257:00 amRNSInterim Results
7th Mar 202510:18 amRNSHaydale US sales process update
10th Feb 20257:00 amRNSHaydale US placed into insolvency process
30th Dec 20245:20 pmRNSReplacement: Result of AGM
30th Dec 202412:48 pmRNSResult of AGM
23rd Dec 20247:05 amRNSDisposal of Korean Subsidiary
23rd Dec 20247:00 amRNSBusiness Review and Appointment of CEO
6th Dec 20247:00 amRNSPosting of Annual Report and Notice of AGM
4th Dec 20249:44 amRNSHolding(s) in Company
3rd Dec 20245:38 pmRNSHolding(s) in Company
2nd Dec 20247:00 amRNSFinal Results

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.